· Original article
Nvidia Vera CPU tests show double throughput at Modal
Modal reports twice the sandbox throughput in early Nvidia Vera CPU tests, but adding Arm support still requires infrastructure and software changes.
FINANCEVELIX / News
Listed companies, earnings, corporate developments and equity markets. Company and asset tags identify the subjects of a story.
Choose topics to see up to three latest articles per topic in your account.
Your topic choices are private to your account. No email or push notifications.
Please wait…
Read the original source and publication date in each article.
Results: 4,017 · Page 269 / 335
· Original article
Modal reports twice the sandbox throughput in early Nvidia Vera CPU tests, but adding Arm support still requires infrastructure and software changes.
· Original article
Halliburton earnings show adjusted EPS rose to $0.60 in Q3 2026 as international growth offset weaker North American sales. Revenue held at $5.7 billion.
· Original article
The Multiconsult merger proposal with Rejlers was on the October 19 shareholder meeting agenda, with unanimous board backing but no confirmed vote outcome.
· Original article
The JetBlue upgrade to Neutral follows a 33% share decline, with UBS citing revenue momentum and cash reserves despite continued losses.
· Original article
Amazon says TorchNeuron software lets PyTorch code run on Trainium without a rewrite, targeting a barrier to switching AI chips away from Nvidia.
· Original article
Kane Biotech plans to showcase revyve and present data at the Wounds Canada conference in Niagara Falls, Ontario, on October 22–24, 2026.
· Original article
Red Cat acquisition proposal offers €39 a share for Steyr Motors, aiming to strengthen its maritime drone business while awaiting approvals and shareholder tenders.
· Original article
GoldInxs financing totals $1.25 million after a second closing, with a higher offering ceiling, Fishpot exploration plans and three new directors.
· Original article
GFL sale talks reportedly involve competing private-equity groups and bids of $50–$55 a share, but the company has not announced a definitive deal.
· Original article
AnaptysBio shares rose on October 19 as the FDA expanded Jemperli’s label to a defined rectal cancer population, four months ahead of its goal date.
· Original article
BAWAG earnings reached €248 million in Q3 2026 as revenue rose, while deposit competition and a shift toward consumer lending added pressure.
· Original article
Fifth Third earnings were released on October 19, 2026, alongside a management call. The available opening remarks contain no financial results.
Charts and market data by TradingView. Availability and delays vary by exchange.